In the Solt-Faber model DENA and 2-Acetamino¯uorene (AAF) treatment combined with hepatectomy induces hepatocellular carcinoma in rats. In this model AAF blocks proliferation of hepatocytes, while oval cells restore liver mass. Here we studied the molecular mechanism involved in blocking AAF-dependent cell cycle progression of hepatocytes. AAF inhibits cell proliferation of hepatocytes shown by the lack of Cyclin E expression before the G1/S phase restriction point. Immun¯uorescence studies revealed that Cyclin E positive signals were restricted to oval cells, while hepatocytes remained negative. Additionally, AAF treatment induces strong nuclear p53 expression which is associated with increased p21 mRNA levels. Inhibition of active Cyclin/CdK (cyclin dependent kinase) complexes is re¯ected in AAF-treated animals by decreased RB expression and phosphorylation. The decrease in RB expression and phosphorylation, which is essential in triggering DNA synthesis and Cyclin A expression, leads to a de®ciency in transcriptionally active E2F complex formation after hepatectomy. Thus, two molecular explanations are evident to account for AAF-dependent cell cycle progression of hepatocytes in vivo: ®rst, induction of p53 expression which leads to higher p21 mRNA levels, and second, a lack of Cyclin E expression at the G1/S phase restriction point after hepatectomy.
Introduction
Liver regeneration occurs after partial destruction or removal of parenchymal liver tissue. In rats DNA synthesis in parenchymal cells starts 12 ± 16 h after removal of two-thirds of the liver by hepatectomy and reaches a peak at around 24 h after surgery (Grisham, 1962) . Dierent factors are involved in regulating the transition from resting to dividing cells (Michalopoulos, 1997) . In recent years it has been shown that cytokines, for example TNFa and IL-6, control the activation of transcription factors like NF-kB and STAT3 which are essential in triggering DNA synthesis of hepatocytes during this multi-step process (Cressmann et al., 1995; Trautwein et al., 1996a , Tewari et al., 1992 .
The process of liver regeneration can be inhibited, especially early within the cell cycle before S phase starts. Experiments with genetically-manipulated animals such as TNF-R1 or IL-6 knock out mice results in a block of hepatocyte proliferation in G1 phase associated with an inhibition of nuclear events triggering DNA synthesis (Yamada et al., 1997; Cressmann et al., 1996) .
In addition to proteins which block signalling pathways of pro-proliferative stimuli, speci®c factors have been described which are able to block cell cycle progression of hepatocytes. p21 has been shown to eectively block this process even in hepatocytes after partial hepatectomy. Transgenic mice expressing p21 in the liver under the control of a hepatocyte-speci®c promoter subjected to two-thirds hepatectomy were unable to restore liver mass, because p21 expression blocked G1/S phase transition (Wu et al., 1996) . This is in contrast to the events in normal animals after two thirds hepatectomy, where a decline in p21 expression has been described during the transition between the G1 phase and start of S phase which is followed by the start of DNA-synthesis (Albrecht et al., 1997) . p21 is one of the members of the CKl (cyclin dependent kinase inhibitor) family regulating RB protein phosphorylation by CdK (cyclin dependent kinase) inhibition. The transcription of the p21 gene is under the control of p53 binding to the p21 promoter region. These control mechanisms are essential for the prevention of hepatocarcinogenesis. This is supported by the fact that loss of heterocygosity and mutations in the DNA binding domain of p53 are frequently observed in hepatocellular carcinomas (HCCs) (Nishida et al., 1997) .
Several animal models have been developed to study hepatocarcinogenesis in vivo. In the Solt-Farber model rats were fed with a combination of diethylnitrosamine (DENA) and 2-acetylamino¯uorene (AAF), followed by hepatectomy. Pretreatment with AAF inhibits cell cycle progression of hepatocytes before DNA synthesis starts (Solt and Farber, 1976) . However, bile-duct epithelial cell also referred to as oval cells do not lose their ability to proliferate after partial hepatectomy in rats pre-treated with AAF (Petersen et al., 1998) .
The proliferation and dierentiation of oval cells into hepatocytes in this model attracted much attention. A step-wise activation of hepatocyte-speci®c transcription factors was described in oval cells during their dierentiation into hepatocytes (Bisgaard et al., 1996) . It has therefore been suggested that oval cells may be liver progenitor cells which are represented by cells lining the bile ductulus or by nondescript periductular cells (Fausto, 1990; Sigal et al., 1992 , Thorgeirsson, 1993 .
In contrast to the well-described proliferation of oval cells, little attention has been focused on the inability of DENA/AAF pre-treated hepatocytes to contribute to restoration of liver mass by entering the cell cycle. Earlier studies indicated that the block of cell proliferation in hepatocytes occurred before the start of DNA synthesis. In this study we investigated mechanisms involved in blocking cell cycle progression of hepatocytes in DENA/AAF treated animals.
Results

AAF treatment triggers proliferation of oval cells and induces premalignant foci in the liver
After two-thirds hepatectomy several growth factors are essential to trigger cell cycle progression of hepatocytes (Michalopoulos and DeFrances, 1997) . Previous studies have demonstrated that animals exposed to AAF and DENA prior to hepatectomy are unable to compensate loss of liver mass by hepatocyte proliferation (Solt and Farber, 1976) . In contrast to hepatocytes, oval cells start to divide and dierentiate into hepatocytes (Evarts et al., 1987) at a later stage. Therefore, we were interested to demonstrate proliferation of oval cells in AAF/DENA treated animals (AAF group). To dierentiate between oval cells and hepatocytes, we used an antibody directed against a-vimentin which is highly expressed in oval cells, but not in hepatocytes.
Before hepatectomy a-vimentin-positive cells were only localized in the periportal area and bile ducts ( Figure 1a) . After hepatectomy the number of avimentin-positive cells increased around the periportal area and in the lobuli of the AAF/DENA treated group reaching a maximum 3 ± 5 days after hepatectomy ( Figure 1b) . After this time the number of avimentin-positive cells decreased and after more than 10 days following hepatectomy positive signals were clearly restricted to the periportal region (Figure 1d ). This observation was in contrast to the regeneration pattern of the control group which received only DENA followed by hepatectomy. No a-vimentinpositive cells were found outside the periportal area indicating that oval cell proliferation is not relevant for liver mass restoration in control treated animals ( Figure 1c) .
The AAF/DENA/hepatectomy model induces malignant growth of hepatocytes (Faris et al., 1991) . Dierentiated parenchymal cells ful®ll several vital functions including control of glucose homeostasis. PAS staining was performed to investigate whether subsets of hepatocytes are unable to store glycogen and thus maintain their role in gluconeogenesis as a liver speci®c-function. As indicated in Figure 2a , 3 days after hepatectomy in the AAF/DENA treated animals foci of cells containing clear cytoplasm with strongly reduced PAS staining were found. These foci were always located in close proximity to periportal areas but not close to the central veins. These results were consistently obtained in all specimens removed from the four animals at the indicated time points. This is in contrast to the ®ndings in the control DENA treated group (Figure 2b) . Therefore, our results indicate that in the livers of the AAF/DENA/hepatectomy treated animals, foci of enzyme altered hepatocytes can be detected 3 days after surgery. Figure 3 shows that multifocal tumours had developed within the livers 10 ± 12 months after partial hepatectomy. Oval-speci®c markers were used to determine if the origin of these tumours was derived from oval cells. Stainings with antibodies to avimentin, cytokeratine 7 and 19 were perfomed (Figure 3) . The results obtained indicate that the tumours arose from the oval cells and not hepatocytes. HE staining revealed tubular structures in some areas of the tumours, while cells with high nuclear/ cytoplasm ratio were also seen (Figure 3a,b) . Cytokeratine 7 positive cells were not detected in normal liver tissue (Figure 3c ) while undierentiated tumour cells strongly express this intermediate ®lament (Figure 3d) . A comparable pattern was found, using anti-Cytokeratine 19 antibodies. Expression of cytokeratine is restricted to tumour tissue ( Figure 3e ) and did not appear in normal liver tissue (Figure 3f ). In part of Figure 3g , the expression of a-vimentin could be detected within the tumour lesions only, but not in hepatocytes (upper right corner).
AAF treatment blocks cell cycle progression of hepatocytes
A previous report indicated that hepatocytes in animals treated with AAF/DENA are unable to proliferate after hepatectomy (Solt and Farber 1976) . Therefore, we investigated at which time during the cell cycle hepatocytes lose their ability to progress in the hepatectomized AAF/DENA treated animals. Thus, we prepared nuclear extracts from treated and control animals to analyse the expression of dierent cyclins, which demonstrate cell cycle-dependent variation after hepatectomy.
In untreated rats DNA-synthesis starts 12 ± 16 h after hepatectomy (Grisham, 1962) . In the DENA treated control group nuclear expression of Cyclin A was clearly evident after 24 h indicating a normal pattern of cell cycle progression after hepatectomy (Figure 4a ). The AAF group is distinguished from the control group by the absence of cyclin A expression 24 h after hepatectomy (Figure 4b ). However a slight increase in nuclear Cyclin A expression appeared 48 h after surgery and a more prominent expression was detected at 72 h.
These results showed that AAF blocked cell cycle progression of hepatocytes before entering S phase after hepatectomy. During the G1 phase of the cell cycle ®rst Cyclin D followed by Cyclin E are expressed. The nuclear expression of both cyclins was investigated further by Western blot analysis. As demonstrated in Figure 4c , the increase in nuclear expression of Cyclin E started 12 h after hepatectomy in DENA treated animals. An eightfold higher Cyclin E expression was found after 24 h, while the level decreased again 48 h after surgery. This pattern of regulation clearly diered in animals which underwent additional AAF-treatment (Figure 4d ). There was no increase in Cyclin E expression at 12 h and only a threefold increase compared to the pretreatment level was found after 24 h. At 48 h after hepatectomy Cyclin E expression decreased to pretreatment levels while there was again a slight upregulation at 72 h (Figure 4d ). The regulation of Cyclin E was also con®rmed by Northern blot analysis (data not shown).
Cyclin D is expressed in the liver in its isoforms, Cyclins D1 and D2. Both ful®l the same function in cell cycle control by activating CdK 4 and/or CdK 6. Control-treated animals expressed a twofold higher Cyclin D level as early as 2 h post-hepatectomy ( Figure  4e ). This level persisted throughout the observation period. In the AAF group, Cyclin D levels increased slightly within the ®rst hour after hepatectomy, but returned to basal levels at later time points for up to 24 h post-hepatectomy. The dierences in Cyclin D expression were not signi®cant between AAF-and control-treated animals ( Figure 4f ).
Western Blot analysis also revealed changes in the nuclear expression of Cyclin A and E in the AAF/ DENA treated animals after hepatectomy, even though they were less pronounced in comparison to control treated animals. To determine the lobular distribution pattern of both cyclins, double immuno¯uorescence studies were performed with antibodies directed against either Cyclin A or E and an oval cell speci®c antibody, anti-OV-1. In Figure 5 , time points depicted correspond to maximum levels of expression detected by Western blot experiments for either Cyclin A or E in AAF-treated rats.
In control treated animals a homogeneous distribution of positive nuclei was found throughout the remaining liver for Cyclin E 24 h and Cyclin A 48 h after hepatectomy (Figure 5b ,f). In contrast, AAF treatment led to a restriction of positive cells to the periportal area (Figure 5d ,h). Double immunofluorescence staining with anti-OV-1 clearly showed that increased Cyclin A and E expression was almost exclusively found in OV-1 positive and thus oval cells (Figure 5c, d and g, h) . These results indicate that the weak positive signals for Cyclin A and E found by Western blot experiments in AAF-treated animals were due to the proliferative response of the oval cells located in the periportal area.
AAF treatment results in higher p53 and p21 expression
Cellular stress induced by DNA-damaging agents may result in the induction of p53 expression which could lead to a block of cell cycle progression (Kastan et al., 1991) . Nuclear p53 expression was investigated by Western blot analysis of nuclear extracts. In control treated animals the p53 protein was not detected in nuclear extracts ( Figure 6a ). As a positive control, nuclear extracts of the human hepatoma cell line HuH-7, which expresses a mutated form of p53, were included in Western blot analysis ( Figure 6a , lane 8).
Compared to the control animals, in AAF-treated rats a strong increase in the nuclear expression of p53 as early as 6 h after hepatectomy was detected ( Figure  6b ). Later, the nuclear expression of p53 increased further reaching a maximum level after 18 h. At 24 and 48 h after hepatectomy p53 expression decreased again ( Figure 6b ). However, after longer exposure of the membrane the expression of p53 was detected before hepatectomy in AAF-treated animals but was absent in the control group (data not shown).
To determine the relevance of p53 expression and AAF treatment for cell cycle progression, FACS scans of propidium iodide stained cells were performed. The cells were treated for 24 h with 150 mM AAF/ml or the carrier solution (DMSO) alone. Two hepatoma cell lines Hep G2 and Hep 3B which either express functional wild type (wt) p53 or no p53 respectively were included in this analysis. FACS analysis revealed a block in G1 phase of the cell cycle when Hep G2 cells were treated with AAF ( Figure 7c , lower panel). G2 phase was signi®cantly reduced from 32.69 to 13.61%, compared to control treated Hep G2 cells (Figure 7c ). The same experiments were performed in the p53-negative Hep 3B cell line. As shown by FACS analysis in this cell line, 150 mM AAF/ml had no signi®cant Figure 4 AAF treatment inhibits the expression of cyclins involved in hepatocyte proliferation after hepatectomy. The nuclear expression of Cyclin A (a,b), Cyclin E (c,d) and Cyclin D (e,f) was investigated in control (a,c,f) and AAF (b,d,e) treated animals. Nuclear extracts were prepared before and at dierent time points after hepatectomy as indicated. Western blot analysis was performed with either an anti-Cyclin A, E or D antibody eect on G1 progression compared to the control group (Figure 7a, upper panel) , where cells in G2 phase were at 27.54 and 24.5% respectively (Figure 7c ).
In both cell lines p53 expression was studied by Western Blot analysis using whole cell lysates. As expected p53 was not detected in Hep 3B cells. In contrast, in Hep G2 cells 150 mM AAF/ml induced p53 expression. Densitometric analysis of p53 expression in the 150 mM AAF-treated cells was fourfold higher compared to the control group (Figure 7b ). The eect of AAF on p53 expression was dose-dependent (data not shown).
P53 induces the expression of several target genes (Chiou et al., 1994) . As hepatocytes were unable to proliferate in the AAF-treated animals after hepatectomy, we studied the regulation of p21/waf1 mRNA. In the p21 promoter functionally active p53 binding sites have been described which increase p21 gene transcription (el Deiry et al., 1994) . Poly A + mRNA was prepared and p21 expression was analysed by Northern blot analysis (Figure 8, upper panel) . Before hepatectomy p21 mRNA was not detected. In AAF-treated animals p21 mRNA expression was ®rst detected 6 h after hepatectomy and peaked after 12 h. Higher p21 mRNA levels were found for up to 24 h after hepatectomy. In the control-treated animals the increase in p21 mRNA expression was not evident 12 h after hepatectomy. However, p21 mRNA levels increased in these animals at 24 h (Figure 8 , upper panel). The membranes were stripped and re-probed with 32 P-labeled GAPDH cDNA to show equal loading of samples on the gel (Figure 8 , lower panel).
In AAF-treated animals is a lack of RB-phosphorylation p21 inhibits CdK-cyclin activity at dierent stages during cell cycle progression (Harper et al., 1995) . As p21 expression was upregulated in the AAF-treated group we further investigated the in¯uence of this on RB expression. Strong RB expression of the hypophosphorylated form was evident in the control group before hepatectomy (Figure 9a ). Following liver resection the signal for RB increased slightly. Additionally, a shift in the migration pattern of RB to a higher molecular weight species was evident corresponding to the hyperphosphorylated form. This increase in the molecular weight of RB was ®rst detected at 2 h and was found for up to 12 h posthepatectomy. During S phase, 24 h after hepatectomy, the nuclear expression of RB decreased again and the migration pattern also returned to the hypophosphorylated form in levels comparable to pretreatment samples (Figure 9a ).
In the AAF-treated animals the RB regulation diered considerably (Figure 9b ). As early as 2 h after hepatectomy, the nuclear expression of RB decreased and fell below the pre-treatment level for up to 18 h. At later time points RB expression increased. Additionally, there was no obvious change in the migration pattern in the AAF-group (Figure 9b ). Figure 5 In AAF treated animals cell proliferation is restricted to oval cells. Liver sections were stained by double immunouorescence with antibodies directed against OV-1 as an oval cellspeci®c antigen (a,c,e,g) and either Cyclin E (b,d) or Cyclin A (f,h). For Cyclin E staining the time point was depicted at 24 h after hepatectomy in control (b) or AAF-treated animals (d). Time points for Cyclin A staining are shown 48 h after hepatectomy in control (f) or AAF-treated (h) rats. OV-1 was visualized using a FITC conjugated (a,c,e,g) and Cyclin A or E a Cy3 conjugated (b,d,f,h) secondary antibody Figure 6 The P53 expression is increased in the AAF treated group after hepatectomy. Western blot analysis with nuclear extracts derived from control (a) and AAF (b) treated animals was performed at dierent time points after hepatectomy. As a positive control (C) nuclear extracts of HuH-7 cell were included expressing a mutated form of p53. An anti-p53 antibody was used to visualize p53 expression Thus, during the ®rst 24 h after hepatectomy no hyperphosphorylated form of RB was found in the liver of AAF-treated animals.
Lack of E2F complex formation in AAF-treated animals
During cell cycle progression active Cyclin/CdK complexes regulate the phosphorylation status of RB. After RB-phosphorylation, E2F is released from the RB-E2F complex (Grana and Reddy 1995; Nasmyth et al., 1996) . Free E2F interacts with DP1 and is now able to activate genes containing E2F binding sites in their promoter regions. These events are crucial for cell cycle progression (Ikeda et al., 1996) . Little information is available about the regulation of E2F after partial hepatectomy. Thus, we studied DNA binding and nuclear expression of E2F in control treated animals ( Figure 10a ).
Gel shift experiments were performed with a consensus E2F motif. As a positive control nuclear extracts of HeLa cells were prepared. HeLa cells express E2F-1 and adeno-viral protein E7, which blocks the E2F binding domain of RB. In these cells E2F does not complex with RB (Arroyo and 150 µM AAF/ml Figure 9 Dierences in the nuclear RB expression between the AAF and control treated group. The nuclear expression of RB was analysed by Western blot experiments. Nuclear extracts before and at time points after hepatectomy were used derived from control (a) and AAF-treated (b) animals. The position of the hypo-and hyperphosphorylated form of RB are shown Raychaudhuri 1992). As expected, a single band was detected in gel shift experiments using HeLa nuclear extracts indicating that free E2F-1 binds to DNA (Figure 10a, lane 5) .
In DENA-treated animals free E2F and E2F-RB could be detected before surgery (Figure 10a upper panel, lane 1). After hepatectomy the gel shift experiments showed that the free E2F/E2F-RB ratio increased re¯ecting higher amounts of free E2F. At 24 h, during S phase, the free E2F/E2F-RB ratio decreased and strong complex formation of the E2F-RB complex was detected (Figure 10a , upper panel, lane 4). In parallel with the gel shift experiments E2F nuclear protein expression was monitored by Western blot analysis which showed an induction of E2F-3 expression during the ®rst 24 h after hepatectomy (Figure 10a, lower panel) .
To con®rm the speci®c interaction between the dierent E2F complexes with DNA, competition gel shift experiments were performed. Increasing amounts of cold oligonucleotides were added to the binding reaction with nuclear extracts prepared 24 h after hepatectomy of control treated animals. These experiments showed that the free E2F and the E2F-RB complex could be readily inhibited by competition with the cold consensus oligonucleotide (Figure 10b )
In contrast to the control group, the E2F binding pattern is dierent with nuclear extracts derived from AAF-treated animals ( Figure 10c, upper panel) . Prior to hepatectomy DNA-binding of E2F complexes was clearly reduced compared to control treated animals. Only a weak complex was evident, indicating binding of free E2F. No complex formation between DNA and E2F-RB was detected. At 6 h after hepatectomy binding of free E2F was further reduced and was not detectable at 12 h while formation of E2F-RB complexes appeared. 24 h after hepatectomy the RB-E2F complex further increased and in addition free E2F binding was detected (Figure 10c, upper panel) .
The nuclear expression of E2F-3 in the AAF group was analysed by Western blot experiments. Nuclear expression of E2F-3 increased for up to 24 h after hepatectomy. The kinetics of the higher E2F-3 expression after hepatectomy in AAF-treated animals was comparable to the DENA-treated control animals ( Figure 10c, lower panel) .
Discussion
In the AAF model, hepatocytes are unable to proliferate and replace liver mass after hepatectomy. However, oval cells which are also thought to be liver stem cells (Alison et al., 1996; Sell et al., 1994) start to enter the cell cycle and restore the loss of functional liver tissue. At a later stage hepatocellular carcinomas are induced in the liver of these animals (Solt and Farber, 1976; Faris et al., 1991) . In our animals multilocular hepatocellular carcinomas were ®rst detected 10 months after hepatectomy and ultimately resulted in death of the animals.
Oval cells and hepatocytes can be distinguished by the expression of dierent intermediate ®laments. To study the proliferation of oval cells in AAF/DENA treated animals a-vimentin was used as a marker. In contrast to oval cells, hepatocytes do not express a- Figure 10 Disruption of E2F complex formation in AAF treated animals. Gel shift experiments were performed with a 32 P-labelled consensus oligonucleotide and nuclear extracts prepared from either control (a) or AAF (c) treated animals (upper panel) at the time points indicated. In (a), lane 5 nuclear extracts derived from HeLa cells were included as a positive control (C). E2F-1 in HeLa cells is unable to interact with RB and therefore only free E2F complexes with DNA. Competition experiments were performed (b) to show the speci®city of the interaction. Increasing amounts of cold E2F consensus oligonucleotide were added to the binding reaction. In (a) and (c) the nuclear expression of E2F-3 before and after hepatectomy was studied by Western blot analysis using an anti-E2F-3 antibody (lower panel) vimentin or cytokeratine 19 (Schirmacher et al., 1993) . In AAF-treated rats a-vimentin positive oval cells were found outside the periportal area within the liver lobuli 3 days after hepatectomy. At a later stage during liver regeneration oval cells dierentiate into hepatocytes. During this process they loose their capacity to express oval-cell speci®c markers like a-vimentin and cytokeratine 19. At 11 days post-hepatectomy a-vimentinpositive cells were restricted to the periportal area, again indicating that liver regeneration which had started with oval cell proliferation was terminated at this stage.
Tumour tissue, removed from animals 10 ± 12 months after hepatectomy, contains undierentiated cells with increased nuclear/cytoplasm ratio. Analysis of intermediate ®lament expression, such as staining for a-vimentin, cytokeratine 7 and 19, determined the origin of these tumour cells as ancestors of oval cells. Tumour tissue shows positive staining for a-vimentin, cytokeratine 7 and 19, while normal liver tissue is negative.
The capacity of oval cells to substitute for the lack of hepatocyte proliferation is essential for the survival of the animals and potentially has therapeutic implications if these cells could be expanded ex vivo. Earlier studies focused mainly on oval cell proliferation and little attention was paid to the molecular mechanisms blocking hepatocyte proliferation in AAF/DENA treated animals (Fu et al., 1988; Bisgaard et al., 1996; Fausto, 1990; Sigal et al., 1992 , Thorgeirrson, 1993 . Our experiments show that hepatocytes are unable to enter S phase after hepatectomy. In comparison, control treated animals showed a normal start of DNA synthesis 24 h after hepatectomy and expression of cyclins which are essential to prepare hepatocytes for S phase. Cell cycle progression in G1 phase is controlled by cyclin dependent kinases, which become activated upon interacting with cyclins. In early G1 CdK4/6 binds to cyclin D followed by CdK2/Cyclin E complexes (Pardee, 1989; Sherr, 1993 , Elledge et al., 1991 , while in S phase CdK2 interacts with Cyclin A (Pagano et al., 1992) .
AAF-treated animals showed reduced and delayed expression of Cyclins A and E. Double immunofluorescence studies were performed to investigate whether dierences in the zonal distribution might account for this observation. These results showed that in AAFtreated rats cell proliferation, re¯ected by higher Cyclin A and E expression, is restricted to oval cells located in the periportal area, while hepatocytes were negative for both proteins.
AAF is a DNA-damaging agent (Linke et al., 1997) . We studied p53 expression in these animals and found a strong enhancement of expression starting 6 h after hepatectomy. However, even before hepatectomy, p53 expression was detectable at a low level in the AAF group, but not in the control group. AAF induces p53 expression in quiescent hepatocytes, but the proproliferative stimuli of liver regeneration further augments the intranuclear level. This observation may result from enhanced p53 transcription or reduced degradation (Gannon et al., 1990; Chowdary et al., 1994) . This ®nding led us to investigate p21 expression, which is transcriptionally controlled through p53 binding sites in its promoter region (el Deiry et al., 1994) . p21 is a member of the CKI family (Sherr and Roberts, 1995) and interacts with cyclin A/CdK2, cyclin D/CdK4/6 and cyclin E/CdK2 complexes (Harper et al., 1995; Chen et al., 1995) . By binding to the CdK/Cyclin complexes in G1, p21 inhibits their activity and thus cell cycle progression (LeBaer et al., 1997) . Higher p21 mRNA levels were evident in the AAF/DENA treated rats starting at the 6 h time point and remaining elevated for up to 24 h. In contrast, this regulation was not found in the control treated animals. Albrecht et al. (1997) have previously reported on the regulation of p21 after hepatectomy. They demonstrated that p21 expression decreases 9 ± 18 h following hepatectomy and increases again after 24 h during S phase. In the control treated animals p21 expression was low after 12 h during G1 and elevated after 24 h in S indicating normal cell cycle progression (Albrecht et al., 1997) .
Inhibition of the cell cycle progression after hepatectomy was also reported in transgenic mice overexpressing the p21 gene under control of a hepatocyte speci®c promoter (Wu et al., 1996) . Liver regeneration was impaired in these animals and associated with an increase in lethality (Wu et al., 1996) . Besides increasing the expression of p21 in hepatocytes, additional mechanisms important in stimulating the growth of oval cells seem to be involved in the AAF/DENA treated rats.
Compared to the control treated animals, the regulation of Cyclin D in the AAF group was only slightly impaired. The alteration in Cyclin D expression between 4 and 24 h does not block G1 progression. Two mechanism might explain this regulation. The strong increase in p53 expression was evident after 6 h, and thus the regulation on the Cyclin D/CdK4 complex might be negligible at the early time points after hepatectomy. Additionally, recent work reported by Albrecht et al. (1998) shows that the Cyclin D/ CdK4 complex is of minor relevance for the regulation of cell cycle progression in liver cells during G1. These results indicate that higher p21 expression in hepatocytes may not inhibit cell proliferation of hepatocytes through the Cyclin D/CdK4 complex. However, a strong dierence was evident in the regulation of Cyclin E between AAF and control treated rats with a lower expression of nuclear Cyclin E 24 h after hepatectomy in the AAF group. High Cyclin E expression during cell cycle progression corresponds to the G1/S restriction point (Herrera et al., 1996) . Therefore, two mechanisms seem essential in blocking hepatocyte proliferation in AAF treated animals at the G1/S-restriction point. As less Cyclin E expression was evident, especially in hepatocytes, this observation would indicate a lower amount of CdK/Cyclin E complexes. Additionally, as p21 is elevated at that time point, when CdK/Cyclin E interaction is most likely to occur, it blocks its activity.
In quiescent cells hypophosphorylated RB complexes with one of the E2F family members of transcription factors (Weinberg, 1995; Ikeda et al., 1996) . In hepatocytes mainly E2F-3 is expressed (Lees et al., 1993) . Active CdK/Cyclin complexes phosphorylate RB during G1 (Grana and Reddy, 1995; Morgan, 1995) and the hyperphosphorylated form loses its capacity to interact with E2F (Almasan et al., 1995; Ikeda et al., 1996) . After E2F is released from RB it binds DP-1 to form a transcriptionally active complex on DNA (Xu et al., 1995) . E2F/DP-1 controls the transcription of target genes during G1, like Cyclin E and A which are essential for cell cycle progression (Schnier et al., 1996; Ohtani et al., 1995; .
There is only limited information about the regulation of E2F-3 following hepatectomy. In control treated animals, gel shift and Western blot (Slansky et al., 1993) analysis demonstrated that the amount of free E2F-3 increases during G1 phase as expected. However, after 24 h in S phase the E2F-RB complex is higher again correlating with the RB phosphorylation status. This regulation is not found in the AAF group. While E2F-3 is expressed in the nuclei, as shown by Western blot analysis, complex formation of E2F or E2F-RB with DNA is dramatically reduced and no increase in free E2F-3 was found after hepatectomy. Therefore, these results suggest a novel molecular mechanism which contributes to the lack of Cyclin E and A expression in AAF-treated hepatocytes. Earlier studies indicated that AAF activates PKC which results in the inhibition of Cyclin A and E gene transcription (Livneh and Fishman, 1997) . Therefore, the ®ndings of E2F complex disruption in the AAFtreated group might either be analagous to or enhance the PKC-dependent eect on Cyclin A and E gene transcription.
Nuclear E2F-3 expression increases in AAF/DENA and control treated animals. However, no increase in DNA binding was found in the AAF group. This lack of DNA-binding despite high nuclear expression of E2F-3 in the AAF/DENA treated animals is currently unexplained. As the E2F family members are also controlled at a post-transcriptional level, namely phosphorylation, this could be one potential explanation for the inhibition of E2F DNA binding (Dynlacht et al., 1994) . Alternatively, protein-protein interaction with other partners of E2F might also be relevant to explain this observation (Dynlacht et al., 1994) .
Presently the fate of hepatocytes unable to proliferate and showing high p53 expression is unclear. Besides inhibiting cells cycle progression, additional functions have been linked to higher p53 expression. p53 may also be involved in triggering apoptosis (Chiou et al., 1994) . Therefore, it could be relevant to examine this aspect in the AAF/DENA model. Initial experiments show that in the AAF/DNA treated rats there is an increase in DNA laddering compared to control treated animals. These results would indicate that in addition to its role for HCC development the AAF model could be an interesting model to study the role of higher p53 expression in vivo on the development of apoptosis as well as cell cycle progression.
In summary, our results show for the AAF/DENA model that hepatocytes are unable to proliferate and restore liver mass after hepatectomy. The molecular explanation for these ®ndings seems to be two parallel mechanisms: ®rst, a higher p53 expression which leads to higher p21 mRNA levels and second a lack of Cyclin E expression 24 h after hepatectomy. These mechanisms result in the inhibition of hepatocyte proliferation at the G1/S phase check point which is re¯ected by inhibition of RB-phosphorylation leading to the disruption of E2F complex formation. Further experiments are now in progress to study additional p53-dependent mechanisms in this model.
Materials and methods
2-Acetamino¯uorene, DENA treatment, two third hepatectomy and preparation of nuclear extracts Four to six-week old Sprague-Dawley rats were obtained from the animal facility of the Medizinische Hochschule Hannover. The animals were maintained on a 12 h night and 12 h light schedule.
Three weeks before hepatectomy DENA (200 mg/kgBW) was administered to all animals by intraperitoneal injection. One week before hepatectomy rats were given 0.02% AAF (Sigma Chemicals, St. Louis, USA) with their standard diet. Control treated animals were fed with the standard diet alone.
Twelve hours before hepatectomy food was withheld from the animals. Animals were anaesthestized with a combination of rompun/ketamine. After a small subxyphoid incision two third hepatectomy was performed as described previously (Trautwein et al., 1996b) . Following surgery the abdominal cavity was closed and animals maintained alive until the remaining liver was removed.
For each time point indicated routinely four rats were used in parallel. The remaining livers were removed, pooled, rinsed in ice cold PBS and partially frozen in liquid nitrogen. Liver nuclei were prepared as described before (Trautwein et al., 1996b) . All steps were performed at 48C.
SDS-polyacrylamide-gel electrophoresis and Western blot analysis
Nuclear extracts were separated on a 10% SDS-polyacrylamide gel and blotted onto a nitrocellulose membrane (Schleicher and Schuell) in 1% SDS, 20% Methanol, 400 mM glycine, 50 mM Tris-HCl pH 8.3, at 48C for 2 h at 200 mA as described previously (Trautwein et al., 1996b) . Western blot analysis was performed. Membranes were probed with anti-Cyclin A (a generous gift of Wilhelm Krek, FMI Basel Switzerland), anti-Cyclin D1 (Upstate Biotechnology, NY, USA), anti-p53 (Oncogene Science), anti-pRB (Pharmingen, San Diego, USA, clone G3-245), anti-E2F-3 (St. Cruz, USA) and anti-Cyclin E (a generous gift of Michael Strauss, MDC, Berlin, Germany). The antigen-antibody complexes were visualised using the ECL detection system as recommended by the manufacturer (Amersham, Braunschweig, Germany). Western Blot Analysis was performed for each protein of interest at least three times.
Northern blot analysis
Northern blot analysis was performed according to standard procedures. Total RNA was isolated by the guanidiumisothiocyanate method (Niehof et al., 1997) . Subsequently, poly(A) + mRNA was prepared. Twenty micrograms of poly(A) + mRNA was run in a 1% agarose formaldehyde gel, followed by transfer to Hybond N membranes (Amersham, Braunschweig, Germany). The p21 and GAPDH cDNA probes were labelled with a 32 P-dATP using a Random priming kit (Boehringer Mannheim, Germany). Hybridization procedure was performed as described previously (Niehof et al., 1997) . For quanti®cation blots were exposed for autoradiography and to an Image plate (Fuji). The counts of the p21 signal were distributed through the counts of the GAPDH signal and set to 1 for animals before hepatectomy.
Gel retardation assays
Gel shift experiments were performed as described before (Trautwein et al., 1993) . Liver nuclear extracts were incubated with a 32 P-labelled consensus E2F site in 16binding buer (25 mM HEPES, pH 7.6, 5 mM MgCl 2 , 34 mM KCl, 2 mM DTT, 0.2 mM PMSF, 1 mg/ml poly (dldC), 2 mg/ml bovine serum albumin). 3.5 mg of liver nuclear extracts or extracts of HeLa cells were incubated for 30 min on ice. Free DNA and DNA-protein complexes were resolved on a 4% TBE-polyacrylamide gel. For competition experiments unlabelled (cold) consensus E2F oligonucleotide was added to the binding reaction.
Cell culture
Hep 3B (wt p53 +/+ ) (ATCC) and Hep G2 (p53 7/7 ) (ATCC) hepatoma cell lines were grown in Dulbeco's modi®ed eagle medium (DMEM) supplemented with 10% foetal calf serum (FCS). Cells were grown to about 50% con¯uency before treatment with AAF.
AAF was dissolved in DMSO to a ®nal concentration of 150 mM/ml. The medium of control cells contained the corresponding amount of DMSO alone.
FACS proliferation analysis
5610
6 cells were incubated in 150 mM AAF/ml for 24 h. For FACS analysis cells were trypsinized, centrifuged and washed three times in PBS. Cells were incubated in 0.05 mg/ml Propidium Iodide, 0.1% sodium Citrate and 0.1% Triton X-100 in the dark overnight at 48C. After four washes in PBS the cells were sheared by aspirating through a needle (0.5623 mm).
The samples were analysed with a Becton-Dickinson FACS scan using the CellQuest TM software. To examine p53 expression a separate aliquot of cells was lysed in Laemmli sample buer and analysed in parallel by Western blot analysis (Tewari et al., 1992) .
Immuno¯uorescence studies
For immuno¯uorescence experiments cryosections (4 ± 5 mm thick) were performed and immediately ®xed for 5 min in icecold acetone, air dried and either stored at 7808C or used immediately. Immuno¯uorescence staining was performed as described previously (Trautwein et al., 1998) . Anti-Cyclin E and anti-OV-1 (a generous gift of B Sell, NY, USA), were both used as primary antibodies and Cy3 conjugated antirabbit IgG (Sigma, St. Louis, USA) and FITC conjugated anti-mouse (Dianova, Hamburg, Germany) were used as secondary antibodies. Sections were analysed through either a 615 nm ®lter (Cy3 staining) or a 525 nm ®lter (FITC staining) with a Olympus¯uorescence microscope (Hamburg, Germany). Identical protocols were used for immunouorescence staining using an anti-Cyclin A antibody.
PAS-staining
Cryosections of liver tissue were ®xed for 5 min in ice-cold acetone and air dried. Samples were incubated for 10 min in 1% periodic acid, followed by three washes in distilled water and 15 min in Schi's Solution (3 g Pararosanilin, 3 ml conc. HCl, 6 g Sodium Disulphite, 200 ml distilled water). Finally, cryosections were washed three times in Sul®twater. Counterstaining of nuclei was performed with Hematoxylin.
Immunohistochemistry HE-staining was performed according to standard procedures. Immunohistochemistry was performed as described previously (Bock et al., 1997) . Endogenous peroxidase was blocked by preincubation in 10% H 2 O 2 for 10 min. Antibodies against intermediate ®laments a-vimentin, cytokeratine 7 and 19 were purchased by Dako (Denmark). Antibodies were incubated for 1 h at RT, washed three times in PBS and incubated overnight at 48C with secondary antimouse IgG (DAKO, Hamburg, Germany). Chromogen reaction was performed according to manufacturers instructions and sections were analysed with an Olympus microscope (Hamburg, Germany).
